Developing a new class of engineered live bacterial therapeutics to treat human diseases

The role microbes play in human health and the ability of synthetic biology to engineer microbial properties opens up new ways of treating disease. In this perspective, the authors describe the design and development of these living therapeutics.

Guardado en:
Detalles Bibliográficos
Autores principales: Mark R. Charbonneau, Vincent M. Isabella, Ning Li, Caroline B. Kurtz
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/26fba4ca08df4eda919a1a6132d74277
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:The role microbes play in human health and the ability of synthetic biology to engineer microbial properties opens up new ways of treating disease. In this perspective, the authors describe the design and development of these living therapeutics.